Jeffrey C. Wang, MD

Professor of Orthopaedic Surgery (Clinical Scholar)

Co-Director of the USC Spine Center

Image of Jeffrey C. Wang, MD
Is this your profile? Click to edit

Overview

Jeffrey C. Wang, MD, is a recognized expert in the surgical treatment of all neck and back disorders. As a world-renowned leader in spine care, Dr. Wang is continuously writing and presenting professional articles, publications, and speaking engagements to national and international audiences. Dr. Wang’s reputation for consistently providing excellent patient care, outstanding qualifications and experience has earned him immense respect from patients and physicians alike. He assumes numerous leadership roles in nationally respected medical organizations, including serving as president of the North American Spine Society, the Cervical Spine Research Society and Society for Brain Mapping and Therapeutics.

His research interests include gene therapy for the treatment of spinal disorders, minimally invasive surgery for spinal disorders, bone growth biological proteins and biomedical engineering of noninvasive spine surgery using high intensity focused ultrasonic waves. Dr. Wang has received numerous research grants and is currently involved in many clinical trials in the treatment of spine problems.

Awards

  • American Orthopaedic Association (AOA): Executive Board
  • American Board of Orthopaedic Surgery (ABOS): Writing Task Force
  • AOSpine International: Past Chairman
  • The Global Spine Journal: Editor in Chief
  • The 5th Annual Global Spine Congress, Dubai, UAE: Program Chair, 2016
  • Orthopedics This Week: Top 26 Spine Surgeons, 2016
  • Pasadena Magazine: Top Doctor, 2016
     – 2017
  • Castle Connolly: America’s Top Doctors, 2016
     – 2017
  • North American Spine Society: President, 2019
  • Cervical Spine Research Society: Past President, 2018
  • Society for Brain Mapping and Therapeutics: Past President

Publications

  • National Trends in Lumbar Degenerative Spondylolisthesis With Stenosis Treated With Fusion Versus Decompression. Neurospine. 2024 Dec; 21(4):1068-1077.. View in PubMed
  • How Reliable is the Assessment of Fusion Status Following ACDF Using Dynamic Flexion-Extension Radiographs? Global Spine J. 2025 May; 15(4):2450-2457. Martin CT, Yoon ST, Alluri RK , Benzel EC, Bono C . View in PubMed
  • What Radiographic and Spinopelvic Parameters do Spine Surgeons Consider in Decision-Making for Treatment of Degenerative Lumbar Spondylolisthesis? Global Spine J. 2025 Jun; 15(5):2645-2651. Cabrera JP . View in PubMed
  • Changes in Segmental and Lumbar Lordosis Following Lumbar Interbody Fusion: A Systematic Review and Meta-Analysis. Clin Spine Surg. 2025 07 01; 38(6):294-303.. View in PubMed
  • We Need RI and Not Just AI! Thoughts on the Implementation of Artificial Intelligence in Medicine and Spine Surgery Specifically. Global Spine J. 2024 Nov; 14(8):2213-2215.. View in PubMed
  • Practice preference and evidence analysis on topical use of tobramycin powder in lumbar spine surgery: A Multi-National AO spine survey with systematic review of the literature. World Neurosurg X. 2024 Oct; 24:100397.. View in PubMed
  • Risk of Subsequent Hip Fractures across Varying Treatment Patterns for Index Vertebral Compression Fractures. J Clin Med. 2024 Aug 14; 13(16).. View in PubMed
  • Lumbar Fusions in Patients with Sickle Cell Disease: A Propensity-Matched Analysis of Postoperative Complications. World Neurosurg. 2024 10; 190:e435-e442.. View in PubMed
  • Systematic Review and Meta-Analysis of the Effect of Osteoporosis on Fusion Rates and Complications Following Surgery for Degenerative Cervical Spine Pathology. Int J Spine Surg. 2024 Jul 04; 18(3):277-286.. View in PubMed
  • Global Spine Journal and Global Spine Congress. Global Spine J. 2024 Jul; 14(6):1689.. View in PubMed